EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity

Prabhat K Purbey, Joowon Seo, Manash K Paul, Keisuke S Iwamoto, Allison E Daly, An-Chieh Feng, Ameya S Champhekar, Justin Langerman, Katie M Campbell, Dörthe Schaue, William H McBride, Steven M Dubinett und 3 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.114289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Prabhat K Purbey und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA; Department of Microbiology, Imm…. Hauptthemen laut MEDLINE: Interferon Regulatory Factor-1. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIAMS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type I interferon (IFN-I) and IFN-γ foster antitumor immunity by facilitating T cell responses. Paradoxically, IFNs may promote T cell exhaustion by activating immune checkpoints. The downstream regulators of these disparate responses are incompletely understood. Here, we describe how interferon regulatory factor 1 (IRF1) orchestrates these opposing effects of IFNs. IRF1 expression in tumor cells blocks Toll-like receptor- and IFN-I-dependent host antitumor immunity by preventing interferon-stimulated gene (ISG) and effector programs in immune cells. In contrast, expression of IRF1 in the host is required for antitumor immunity. Mechanistically, IRF1 binds distinctly or together with STAT1 at promoters of immunosuppressive but not immunostimulatory ISGs in tumor cells. Overexpression of programmed cell death ligand 1 (PD-L1) in Irf1-/- tumors only partially restores tumor growth, suggesting multifactorial effects of IRF1 on antitumor immunity. Thus, we identify that IRF1 expression in tumor cells opposes host IFN-I- and IRF1-dependent antitumor immunity to facilitate immune escape and tumor growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Regulatory Factor-1AnimalsHumansMiceB7-H1 AntigenCell Line, TumorImmunityMice, Inbred C57BLNeoplasmsSTAT1 Transcription FactorMaleFemale

Stichwörter der Autor:innen

CP: CancerCP: ImmunologyIRF1PD-L1 regulationTLR signalingantitumor immunitycytotoxic T lymphocytesimmune checkpoint blockadeimmune evasioninterferon signalingscRNA-seqtranscription

Substanzen

B7-H1 AntigenInterferon Regulatory Factor-1IRF1 protein, humanIrf1 protein, mouseSTAT1 Transcription Factor

Autor:innen und Institutionen

  • Department of Medicine, Division of Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UC…
  • Department of Medicine, Division of Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
  • Department of Medicine, Division of Pulmonology and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA; Department of Radiation Biology and Toxicology, Manipal School of Life Sci…
  • Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
  • Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
  • Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Förderung

  • NIAID NIH HHS
  • NIAMS NIH HHS
  • NCI NIH HHS
  • CSRD VA
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institutes of Health
  • US Department of Veterans Affairs
  • Howard Hughes Medical Institute

Zitieren

APA

Purbey, P. K., Seo, J., Paul, M. K., Iwamoto, K. S., Daly, A. E., Feng, A. C., Champhekar, A. S., Langerman, J., Campbell, K. M., Schaue, D., McBride, W. H., Dubinett, S. M., Ribas, A., Smale, S. T., & Scumpia, P. O. (2024). Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114289

Vancouver

Purbey PK, Seo J, Paul MK, Iwamoto KS, Daly AE, Feng AC, et al. Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114289

BibTeX
@article{Purbey2024,
  author = {Purbey, Prabhat K and Seo, Joowon and Paul, Manash K and Iwamoto, Keisuke S and Daly, Allison E and Feng, An-Chieh and Champhekar, Ameya S and Langerman, Justin and Campbell, Katie M and Schaue, Dörthe and McBride, William H and Dubinett, Steven M and Ribas, Antoni and Smale, Stephen T and Scumpia, Philip O},
  title = {Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.114289}
}
Kostenlos starten →